RxDoctor Payments Data

Sean Forsyth

Family · Millsboro, DENPI 1598159568

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,838 of the $3,545 with a category attached, or 80.1%. 36 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 38.9% of the total.

$3,545in general payments, 2019–2025

Across 109 payments — averaging $32.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • Novo Nordisk$283
  • AstraZeneca$264
  • Lilly USA, LLC$222
  • Boehringer Ingelheim$154
  • Johnson & Johnson$132
  • plus $1K from 30 others

What the payments were for

  • Travel & lodging$63118%
  • Food & beverage$2,83880%
  • Other$762%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,545 in reported general payments places this provider in the 85th percentile of 523 family providers in Delaware.

See all family providers in Delaware

Medicare billing

Part B allowed, 2024
$91,887
Medicare patients
651
Services billed
1,221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine-FluticasoneAzelastine/Fluticasone53$5,905
Ipratropium Bromide69$3,268
Fluocinolone Acetonide Oil70$2,698
Famotidine152$2,122
Omeprazole102$1,754
Mometasone Furoate11$1,372
Azelastine Hcl45$1,217
Fluticasone Propionate42$724
Ofloxacin13$713
Levocetirizine Dihydrochloride16$244
Mupirocin18$108
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$98

Paid to pharmacies, not to this prescriber.

Other family in Millsboro

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →